HB 638 TX Introduced
Relating to access to certain investigational drugs, biological products, and devices used in clinical trials by patients with severe chronic diseases.
A state bill is a proposed law in a state legislature — separate from the U.S. Congress. Learn more →
Sponsors (5)
Action history (16)
- Nov 14, 2022 Filed · lower
- Feb 23, 2023 Read first time · lower
- Feb 23, 2023 Referred to Public Health · lower
- Apr 17, 2023 Considered in public hearing · lower
- Apr 17, 2023 Testimony taken/registration(s) recorded in committee · lower
- Apr 17, 2023 Left pending in committee · lower
- Apr 26, 2023 Considered in formal meeting · lower
- Apr 26, 2023 Committee substitute considered in committee · lower
- Apr 26, 2023 Reported favorably as substituted · lower
- May 6, 2023 Comte report filed with Committee Coordinator · lower
- May 7, 2023 Committee report distributed · lower
- May 8, 2023 Committee report sent to Calendars · lower
- May 8, 2023 Considered in Calendars · lower
- May 10, 2023 Placed on General State Calendar · lower
- May 11, 2023 Companion considered in lieu of · lower
- May 11, 2023 Laid on the table subject to call · lower
Subjects
HEALTH & HUMAN SERVICES COMMISSION (V0177)Health--Other Diseases & Medical Conditions (I0383)INFORMED CONSENT (S0057)MARY LOU'S LAW (PO0PB)MEDICAL BOARD, TEXAS (V0644)MEDICINE & PRESCRIPTION DRUGS (S7338)STATE HEALTH SERVICES, DEPARTMENT OF (V0463)
Text versions (4)
Full text
The full text hasn’t been imported yet. CivicGate fetches it from the state legislature’s published version documents — check now.
Comments
Data from OpenStates. View on OpenStates →
Comments